Deficiencies in BDNF/TrkB and NT‐3/TrkC signaling have been observed in the brains of AD patients and mouse models, and have been associated with Aβ and tau accumulation, synapse loss, and cognitive decline.16, 17, 18. Here, MAPT is linked to Alzheimer disease.